Trial Profile
A Randomized Crossover Bioequivalence Study Comparing a Single Dose of Phenylephrine HCl 30 mg Extended Release Tablet to Three Phenylephrine HCl 10 mg Immediate Release Tablets Each Consecutively Dosed Four Hours Apart Under Fed and Fasting Conditions
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Mar 2015
Price :
$35
*
At a glance
- Drugs Phenylephrine (Primary)
- Indications Nasal congestion
- Focus Pharmacokinetics
- Sponsors Merck Sharp & Dohme
- 10 Jun 2014 New trial record